Results of the 2025 AMWA Generative AI Member Survey
DOI:
https://doi.org/10.55752/amwa.2026.528Abstract
Generative artificial intelligence (GenAI) is rapidly transforming medical communication, offering new tools for content creation, summarization, and editing. Although GenAI-assisted writing presents both opportunities and risks, data on how medical communicators are adopting these technologies are limited. To address this limitation, AMWA formed an AI Task Force in 2025 and conducted a survey to understand the current knowledge, experience, and needs of the AMWA membership with respect to GenAI technology. This article presents the survey’s findings, first shared at AMWA’s 2025 Medical Writing & Communication Conference in November. The responses will inform recommendations by the AI Task Force to the Board of Directors on initiatives to support members’ understanding and use of GenAI in medical communication.
Downloads
Published
How to Cite
License
Copyright Notice
Authors of manuscripts accepted for publication retain copyright in their work but are required to grant to AMWA exclusive worldwide first publication rights and further grant a nonexclusive license for other uses of the manuscript for the duration of their copyright as outlined in the Agreement on Authors' Rights and Responsibilities. In the same agreement, authors are required to confirm that the material submitted for publication, both in its paper and electronic versions, including reproductions of other works (eg, photographs, maps, etc.) does not infringe upon any existing copyright.
Any reproduction within two years following the date of publication requires the permission of the Editor-in-Chief of the AMWA Journal.
Contact managingeditor@amwa.org for all requests for reuse.
